CADENCE PHARMACEUTICALS INC's ticker is CADX and the CUSIP is 12738T100. A total of 3 filers reported holding CADENCE PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2013 | $4,336,000 | +43.4% | 479,154 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $3,024,000 | -7.5% | 479,154 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $3,268,000 | +41.7% | 479,154 | +39.1% | 0.00% | +100.0% |
| Q1 2013 | $2,306,000 | +70.7% | 344,564 | 0.0% | 0.00% | 0.0% |
| Q3 2012 | $1,351,000 | -7.5% | 344,564 | 0.0% | 0.00% | 0.0% |
| Q2 2012 | $1,461,000 | – | 344,564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FALCON POINT CAPITAL, LLC | 113,808 | $717,000 | 0.76% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 1,700,000 | $10,711,000 | 0.64% |
| NEA Management Company, LLC | 2,070,286 | $13,043,000 | 0.52% |
| WALL STREET ASSOCIATES | 460,000 | $2,898,000 | 0.27% |
| CR Intrinsic Investors, LLC | 764,922 | $4,827,000 | 0.15% |
| Coe Capital Management, LLC | 20,000 | $126,000 | 0.08% |
| A.R.T. Advisors, LLC | 123,399 | $777,000 | 0.04% |
| ELLINGTON MANAGEMENT GROUP LLC | 19,000 | $120,000 | 0.02% |
| Quotient Investors, LLC | 10,900 | $69,000 | 0.02% |
| MASON STREET ADVISORS, LLC | 249,600 | $1,575,000 | 0.02% |